Subclinical alveolar involvement in ulcerative colitis

Inflammatory Bowel Diseases

Volumn 11, Issue 4, 2005, Pages 372-375

  Gursoy, Sebnem ^a   Guven, Kadri ^a   Kula, Mustafa ^a   Canoz, Ozlem ^a   Yurci, Alper ^a   Unluhizarci, Kursad ^a   Ozbakir, Omer ^a   Yucesoy, Mehmet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Pulmonary dysfunction; Technetium 99m diethylene triamine penta acetic acid; Ulcerative colitis

Indexed keywords

MESALAZINE; PENTETATE TECHNETIUM TC 99M;

ADULT; AEROSOL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG CLEARANCE; LUNG DISEASE; MALE; PERMEABILITY; PRIORITY JOURNAL; SCINTIGRAPHY; SYMPTOMATOLOGY; TISSUE INJURY; ULCERATIVE COLITIS;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERMEABILITY; PULMONARY ALVEOLI; RADIOPHARMACEUTICALS; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M PENTETATE;

EID: 17444390107     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000164019.83666.af     Document Type: Article

References (22)

1. Kraft SC, Earle RH, Roesler M, et al. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med. 1976;136:454-459.
2. Desai SJ, Gephardt GN, Stoller JK. Diffuse panbronchiolitis preceding ulcerative colitis. Chest. 1989;45:1342-1344.
3. Marvisi M, Borello PD, Brianti M, et al. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J. 2000;16: 965-968.
4. Wilcox P, Miller R, Miller G, et al. Airway involvement in ulcerative colitis. Chest. 1987;92:18-22.
5. Gabazza EC, Taguchi O, Yamakamý T, et al. Bronchopulmonary disease in ulcerative colitis. Intern Med. 1992;31:1155-1159.
6. Hilling GAL, Robertson DAF, Chalmers AH, et al. Unusual pulmonary complication of ulcerative colitis with a rapid response to corticosteroids: case report. Gut. 1994;35:847-848.
7. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:104-115.
8. Riley SA, Mani V, Goodman MJ, et al. Comparison of delayed-release 5-aminosalicyclic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology. 1988;94: 1383-1389.
9. Douglas JG, Donald CF, Leslie MJ, et al. Respiratory impairment in inflammatory bowel disease: does it vary with disease activity? Respir Med. 1989;83:389-394.
10. Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine. 1993;72:151-183.
11. Mahadeva R, Walsh G, Flower CDR, et al. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J. 2000;15:41-48.
12. Eade OE, Smith CL, Alexander JR, et al. Pulmonary function in patients with inflammatory bowel disease. Am J Gastroenterol. 1980;73:154-155.
13. Johnson NM, Mee AS, Jewell DP, et al. Pulmonary function in inflammatory bowel disease. Digestion. 1978;18:416-418.
14. Godet PG, Cowie R, Woodman RC, et al. Pulmonary function abnormalities in patients with ulcerative colitis. Am J Gastroenterol. 1997;92:1154-1156.
15. Kuzela L, Vavrecka A, Prikazska M, et al. Pulmonary complication in patients with inflammatory bowel disease. Hepatogastroenterology. 1999; 46:1714-1719.
16. Tzanakis N, Samiou M, Bouros D, et al. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med. 1998; 157:382-386.
17. Louis E, Louis R, Drion V, et al. Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy. 1995;50:729-733.
18. Susskind H. Technetium-99m-DTPA aerosol to measure alveolar-capillary membrane permeability. J Nucl Med. 1994;35:207-209.
19. Robertson DAF, Taylor N, Sidhu H, et al. Pulmonary permeability in coeliac disease and inflammatory bowel disease. Digestion. 1989;42:98-103.
20. Caner B, Ugur O, Bayraktar M, et al. Impaired lung epithelial permeability in diabetics detected by technetium -99m-DTPA aerosol scintigraphy. J Nucl Med. 1994;35:204-206.
21. Ussov WY, Peters AM, Savill J, et al. relationship between granulocyte activation, pulmonary granulocyte kinetics and alveolar permeability in extrapulmonary inflammatory disease. Clin Sci. 1996;91:329-335.
22. Adenis A, Colombel JF, Lecouffe P, et al. Increased pulmonary and intestinal permeability in Crohn's disease. Gut. 1992;33:678-682.